Product image of Onivyde 43mg/10ml (Irinotecan Liposome) 43mg/10ml Vials supplied by GNH India

Onivyde 43mg/10ml

Active Ingredient:
Irinotecan Liposome
Form:
Vials
Brand:
Onivyde 43mg/10ml
Origin:
USA

Onivyde 43mg/10ml (Irinotecan Liposome Vials) 43mg/10ml

Onivyde 43mg/10ml is a liposomal formulation of irinotecan used for cancer treatment. This injectable solution comes in 10ml vials for intravenous use. Store at 2-8°C to maintain stability. Ideal for chemotherapy regimens requiring precise dosing.

Strength

43mg/10ml

Pack Size

1s

Storage

2-8°

Manufacturer / TM Owner

Ipsen Biopharmaceuticals, Inc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Onivyde 43mg/10ml is used in combination with other medications to treat metastatic pancreatic cancer in patients who have previously received gemcitabine-based therapy. It belongs to a class of drugs known as topoisomerase I inhibitors, which work by slowing or stopping cancer cell growth. This formulation is designed to deliver the active drug directly to tumor sites while reducing exposure to healthy tissues.

Side Effects

  • Patients receiving Onivyde 43mg/10ml may experience effects such as nausea, fatigue, or diarrhea, which are common with chemotherapy. Some individuals report changes in appetite or temporary hair thinning. These effects vary based on individual response and treatment duration. Regular monitoring by healthcare providers helps manage these reactions.

Precautions & Warnings

  • Onivyde 43mg/10ml should be handled with care due to its potent nature. It requires proper storage at 2-8°C and must be administered by trained medical professionals. Patients should report any signs of infection, severe diarrhea, or unusual bleeding immediately. Avoid contact with skin or mucous membranes during preparation.

Avoid Interactions

  • Concurrent use of strong CYP3A4 inhibitors or inducers may alter Onivyde 43mg/10ml effectiveness. Medications like ketoconazole or rifampin can impact drug levels in the body. Alcohol and certain supplements may increase side effects. Always inform healthcare providers about all medications and supplements being taken before starting treatment.

Frequently Asked Questions

Onivyde 43mg/10ml is used to treat metastatic pancreatic cancer in patients who have received prior gemcitabine-based therapy.

It is administered intravenously by healthcare professionals in a clinical setting.

Common side effects include nausea, fatigue, and diarrhea. Patients should discuss these with their healthcare provider.

No, it must be stored at 2-8°C to maintain its stability and effectiveness.

Yes, it may interact with strong CYP3A4 inhibitors or inducers. Always disclose all medications to your healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irinotecan Liposome

Onivyde 43mg/10ml

Onivyde 43mg/10ml

43mg/10ml Vials
Onivyde 43mg/10ml

Onivyde 43mg/10ml

43mg/10ml Vials
Onivyde 4.3mg/ml

Onivyde 4.3mg/ml

4.3mg/ml X 10ml Vials

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT